262 related articles for article (PubMed ID: 10470857)
1. Interferon-alpha inhibits proliferation in human T lymphocytes by abrogation of interleukin 2-induced changes in cell cycle-regulatory proteins.
Erickson S; Sangfelt O; Castro J; Heyman M; Einhorn S; Grandér D
Cell Growth Differ; 1999 Aug; 10(8):575-82. PubMed ID: 10470857
[TBL] [Abstract][Full Text] [Related]
2. Diacylglycerol kinase inhibition prevents IL-2-induced G1 to S transition through a phosphatidylinositol-3 kinase-independent mechanism.
Flores I; Jones DR; Ciprés A; Díaz-Flores E; Sanjuan MA; Mérida I
J Immunol; 1999 Jul; 163(2):708-14. PubMed ID: 10395661
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of cell cycle progression by rapamycin induces T cell clonal anergy even in the presence of costimulation.
Powell JD; Lerner CG; Schwartz RH
J Immunol; 1999 Mar; 162(5):2775-84. PubMed ID: 10072524
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-2 expression in human carcinoma cell lines and its role in cell cycle progression.
Reichert TE; Nagashima S; Kashii Y; Stanson J; Gao G; Dou QP; Whiteside TL
Oncogene; 2000 Jan; 19(4):514-25. PubMed ID: 10698521
[TBL] [Abstract][Full Text] [Related]
5. Quantitative and qualitative signals determine T-cell cycle entry and progression.
Modiano JF; Mayor J; Ball C; Chitko-McKown CG; Sakata N; Domenico-Hahn J; Lucas JJ; Gelfand EW
Cell Immunol; 1999 Oct; 197(1):19-29. PubMed ID: 10555992
[TBL] [Abstract][Full Text] [Related]
6. Saikosaponin a inhibits the proliferation and activation of T cells through cell cycle arrest and induction of apoptosis.
Sun Y; Cai TT; Zhou XB; Xu Q
Int Immunopharmacol; 2009 Jul; 9(7-8):978-83. PubMed ID: 19375524
[TBL] [Abstract][Full Text] [Related]
7. Sensitivity of IL-5 production to the cAMP-dependent pathway in human T cells is reduced by exogenous IL-2 in a phosphoinositide 3-kinase-dependent way.
Heijink IH; Kauffman HF; Postma DS; de Monchy JG; Vellenga E
Eur J Immunol; 2003 Aug; 33(8):2206-15. PubMed ID: 12884295
[TBL] [Abstract][Full Text] [Related]
8. Regulatory effects of transforming growth factor-beta on IL-2- and IL-4-dependent T cell-cycle progression.
Ruegemer JJ; Ho SN; Augustine JA; Schlager JW; Bell MP; McKean DJ; Abraham RT
J Immunol; 1990 Mar; 144(5):1767-76. PubMed ID: 2407783
[TBL] [Abstract][Full Text] [Related]
9. Herpes simplex virus type 1 infection imposes a G(1)/S block in asynchronously growing cells and prevents G(1) entry in quiescent cells.
Ehmann GL; McLean TI; Bachenheimer SL
Virology; 2000 Feb; 267(2):335-49. PubMed ID: 10662629
[TBL] [Abstract][Full Text] [Related]
10. A cytokine, lymphocyte blastogenesis inhibitory factor (LBIF), arrests mitogen-stimulated T lymphocytes at early G1 phase with no influence on interleukin 2 production and interleukin 2 receptor light chain expression.
Sugimura K; Ueda Y; Takeda K; Fukuda S; Tsukahara K; Habu Y; Fujiwara H; Azuma I
Eur J Immunol; 1989 Aug; 19(8):1357-64. PubMed ID: 2673797
[TBL] [Abstract][Full Text] [Related]
11. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
12. Switching on of the proliferation or apoptosis of activated human T lymphocytes by IFN-gamma is correlated with the differential expression of the alpha- and beta-chains of its receptor.
Novelli F; Bernabei P; Ozmen L; Rigamonti L; Allione A; Pestka S; Garotta G; Forni G
J Immunol; 1996 Sep; 157(5):1935-43. PubMed ID: 8757312
[TBL] [Abstract][Full Text] [Related]
13. Augmentation of antitumor activity of 5-fluorouracil by interferon alpha is associated with up-regulation of p27Kip1 in human hepatocellular carcinoma cells.
Eguchi H; Nagano H; Yamamoto H; Miyamoto A; Kondo M; Dono K; Nakamori S; Umeshita K; Sakon M; Monden M
Clin Cancer Res; 2000 Jul; 6(7):2881-90. PubMed ID: 10914738
[TBL] [Abstract][Full Text] [Related]
14. Beta-galactoside-binding protein (beta GBP) alters the cell cycle, up-regulates expression of the alpha- and beta-chains of the IFN-gamma receptor, and triggers IFN-gamma-mediated apoptosis of activated human T lymphocytes.
Allione A; Wells V; Forni G; Mallucci L; Novelli F
J Immunol; 1998 Sep; 161(5):2114-9. PubMed ID: 9725202
[TBL] [Abstract][Full Text] [Related]
15. New immunosuppressive drug PNU156804 blocks IL-2-dependent proliferation and NF-kappa B and AP-1 activation.
Mortellaro A; Songia S; Gnocchi P; Ferrari M; Fornasiero C; D'Alessio R; Isetta A; Colotta F; Golay J
J Immunol; 1999 Jun; 162(12):7102-9. PubMed ID: 10358154
[TBL] [Abstract][Full Text] [Related]
16. Suppressor activity of anergic T cells induced by IL-10-treated human dendritic cells: association with IL-2- and CTLA-4-dependent G1 arrest of the cell cycle regulated by p27Kip1.
Kubsch S; Graulich E; Knop J; Steinbrink K
Eur J Immunol; 2003 Jul; 33(7):1988-97. PubMed ID: 12884865
[TBL] [Abstract][Full Text] [Related]
17. Rapamycin blocks cell cycle progression of activated T cells prior to events characteristic of the middle to late G1 phase of the cycle.
Terada N; Lucas JJ; Szepesi A; Franklin RA; Domenico J; Gelfand EW
J Cell Physiol; 1993 Jan; 154(1):7-15. PubMed ID: 8419408
[TBL] [Abstract][Full Text] [Related]
18. Differential regulation of the tumor suppressor molecules, retinoblastoma susceptibility gene product (Rb) and p53, during cell cycle progression of normal human T cells.
Terada N; Lucas JJ; Gelfand EW
J Immunol; 1991 Jul; 147(2):698-704. PubMed ID: 1906503
[TBL] [Abstract][Full Text] [Related]
19. A c-myc antisense oligodeoxynucleotide inhibits entry into S phase but not progress from G0 to G1.
Heikkila R; Schwab G; Wickstrom E; Loke SL; Pluznik DH; Watt R; Neckers LM
Nature; 1987 Jul 30-Aug 5; 328(6129):445-9. PubMed ID: 3302722
[TBL] [Abstract][Full Text] [Related]
20. Human IFN-gamma up-regulates IL-2 receptors in mitogen-activated T lymphocytes.
Rodriguez MA; De Sanctis JB; Blasini AM; Leon-Ponte M; Abadi I
Immunology; 1990 Apr; 69(4):554-7. PubMed ID: 2110548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
